论文部分内容阅读
目的探讨β受体阻滞剂治疗扩张型心肌病心力衰竭的疗效。方法32例扩张型心肌病并充血性心力衰竭患者随机分为治疗组18例和对照组14例,治疗组在心衰从Ⅲ/Ⅳ级转到Ⅰ/Ⅱ级后,予倍他乐克治疗。对照组常规治疗,观察3个月,分析心率血压变化和两组治疗前后心功能变化。结果治疗组各项观察指标均明显改善,病人生活质量有明显提高。结论β受体阻滞剂治疗扩张型心肌病并心力衰竭有良好效果。
Objective To investigate the effect of β-blocker on heart failure of dilated cardiomyopathy. Methods Thirty-two patients with dilated cardiomyopathy and congestive heart failure were randomly divided into treatment group (n = 18) and control group (n = 14). Patients in the treatment group were treated with metoclopril after the heart failure was changed from grade Ⅲ / Ⅳ to grade Ⅰ / . Control group, conventional treatment, observed for 3 months, analysis of changes in heart rate and blood pressure before and after treatment, changes in cardiac function. Results The treatment group significantly improved the observation of all indicators, the quality of life of patients has significantly improved. Conclusion β-blockers have good effect on dilated cardiomyopathy and heart failure.